World's Best Scientists 2026 revealed!
Wolf-Henning Boehncke

Wolf-Henning Boehncke

D-Index & Metrics

Immunology

D-Index
72
Citations
18268
World Ranking
2221
National Ranking
58

Wolf-Henning Boehncke publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Wolf-Henning Boehncke sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 434 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Wolf-Henning Boehncke D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Wolf-Henning Boehncke sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 72 D-Index — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Wolf-Henning Boehncke is affiliated with the University of Geneva in Switzerland. Their research primarily focuses on medical fields including immunology, dermatology, rheumatology, hematology, and pathology. The core areas of study encompass psoriasis treatment and pathogenesis, spondyloarthritis studies and treatments, dermatology and skin diseases, rheumatoid arthritis research and therapies, autoimmune and inflammatory disorders research, health systems, economic evaluations, quality of life, and pharmaceutical studies and practices.

Their published work appears frequently in several key journals and medical publications. Notable publication venues include:

  • Annals of the Rheumatic Diseases
  • JDDG Journal der Deutschen Dermatologischen Gesellschaft
  • Journal of the European Academy of Dermatology and Venereology
  • Journal of the American Academy of Dermatology
  • Revue Médicale Suisse

Wolf-Henning Boehncke has contributed to a range of research papers. Selected recent publications are:

  • EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update, 2024, Annals of the Rheumatic Diseases
  • EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update, 2020, Annals of the Rheumatic Diseases
  • Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial, 2020, The Lancet
  • Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement, 2020, Annals of the Rheumatic Diseases
  • IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications, 2020, Frontiers in Immunology

The frequent co-authors collaborating with Boehncke include:

  • Nicolò Costantino Brembilla
  • Christopher T. Ritchlin
  • A. Kollmeier
  • Iain B. McInnes
  • Philip J. Mease

The scientist's contributions span multiple disciplines within medicine, with a strong emphasis on immune-related conditions affecting skin and joints. The combination of clinical recommendations, therapeutic trials, and immunological research highlights a comprehensive approach to understanding and managing autoimmune and inflammatory diseases.

Best Publications

  • Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

    Laura C. Coates;Arthur Kavanaugh;Philip J. Mease;Enrique R. Soriano

  • EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update

    Laure Gossec;Xenofon Baraliakos;Andreas Kerschbaumer;Maarten de Wit

  • The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond

    Nicolo Costantino Brembilla;Luisa Senra;Wolf-Henning Boehncke;Wolf-Henning Boehncke

  • Psoriasis : a possible risk factor for development of coronary artery calcification

    Ralf J. Ludwig;C. Herzog;A. Rostock;Falk Rudiger Ochsendorf

  • S3 – Guidelines on the treatment of psoriasis vulgaris (English version). Update

    Alexander Nast;Wolf-Henning Boehncke;Ulrich Mrowietz;Hans-Michael Ockenfels

  • Proteasome inhibition: a new anti-inflammatory strategy

    Peter J. Elliott;Thomas Matthias Zollner;Wolf-Henning Boehncke

  • Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement.

    Peter Nash;Andreas Kerschbaumer;Thomas Dörner;Maxime Dougados

  • IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications.

    Esther von Stebut;Wolf-Henning Boehncke;Wolf-Henning Boehncke;Kamran Ghoreschi;Tommaso Gori

  • Pulling the trigger on psoriasis

    Wolf-Henning Boehncke;Daniela Dressel;Thomas Matthias Zollner;Roland Kaufmann

  • TREATMENT OF PSORIASIS BY TOPICAL PHOTODYNAMIC THERAPY WITH POLYCHROMATIC LIGHT

    Wolf-Henning Boehncke;Wolfram Sterry;Roland Kaufmann

  • Managing comorbid disease in patients with psoriasis

    Wolf-Henning Boehncke;Sandra Boehncke;Michael P Schön

  • The molecular basis of lymphocyte recruitment to the skin: clues for pathogenesis and selective therapies of inflammatory disorders.

    Michael P. Schon;Thomas Matthias Zollner;Wolf-Henning Boehncke

  • Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model

    Thomas Matthias Zollner;Maurizio Podda;Christine Pien;Peter J. Elliott

  • German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version).

    Alexander Nast;Ina B. Kopp;Matthias Augustin;Kirstin-Benita Banditt

  • Efomycine M, a new specific inhibitor of selectin, impairs leukocyte adhesion and alleviates cutaneous inflammation

    Michael P. Schon;Thomas Krahn;Margarete Schon;Maria-L Rodriguez

  • Excess beta 2 microglobulin promoting functional peptide association with purified soluble class I MHC molecules.

    Steven Kozlowski;Toshiyuki Takeshita;Wolf-Henning Boehncke;Hidemi Takahashi;Hidemi Takahashi

  • Mycophenolate mofetil is effective in the treatment of atopic dermatitis.

    Marcella Grundmann-Kollmann;Maurizio Podda;Falk Rudiger Ochsendorf;Wolf-Henning Boehncke

  • Familial Juvenile Onset Psoriasis Is Associated with the Human Leukocyte Antigen (HLA) Class I side of the Extended Haplotype Cw6-B57-DRB1*0701-DQA1*0201-DQB1*0303: A Population- And Family-Based Study

    Marcus Schmitt-Egenolf;Marcus Schmitt-Egenolf;Thomas H. Eiermann;Wolf-Henning Boehncke;Markward Ständer

  • Activated, not resting, platelets increase leukocyte rolling in murine skin utilizing a distinct set of adhesion molecules.

    Ralf J. Ludwig;Jeanette E. Schultz;Wolf-Henning Boehncke;Maurizio Podda

  • The ability of different forms of heparins to suppress P-selectin function in vitro correlates to their inhibitory capacity on bloodborne metastasis in vivo

    Ralf J. Ludwig;Susanne Alban;Roxana Bistrian;Wolf-Henning Boehncke

  • Is psoriasis a T-cell disease?

    B. J. Nickoloff;J. M. Schroder;P. von den Driesch;S. P. Raychaudhuri

  • Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis.

    Laura C Coates;Oliver Fitzgerald;Joseph F Merola;Josef Smolen

Frequent Co-Authors

Ralf Ludwig
Ralf Ludwig University of Rostock
Wolfram Sterry
Wolfram Sterry Humboldt-Universität zu Berlin
Michael P. Schön
Michael P. Schön University of Göttingen
Ulrich Mrowietz
Ulrich Mrowietz Kiel University
Matthias Augustin
Matthias Augustin Universität Hamburg
Diamant Thaçi
Diamant Thaçi University of Lübeck
Michel Gilliet
Michel Gilliet University Hospital of Lausanne
Kristian Reich
Kristian Reich University of Göttingen
Alice B. Gottlieb
Alice B. Gottlieb Icahn School of Medicine at Mount Sinai
Lars E. French
Lars E. French Ludwig-Maximilians-Universität München

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, several related online degrees offer promising career opportunities, especially within healthcare and clinical research fields. One common pathway is pursuing a Licensed Practical Nurse (LPN) credential, which can be attained through some of the fastest and easiest lpn programs. These programs allow students to enter the nursing workforce quickly, gaining valuable clinical experience that complements immunological knowledge.

Advancing further, many immunology enthusiasts consider becoming Family Nurse Practitioners (FNPs). The easiest fnp program options provide accessible routes to specialized nursing roles that often intersect with immunological care and patient management.

For those focused on mental health and immune system interactions, Psychiatric Mental Health Nurse Practitioner (PMHNP) programs deliver targeted training. Some of the best psychiatric mental health nurse practitioner programs online also offer excellent clinical placement rates, helping graduates build strong professional networks and hands-on experience.

Cost is a critical factor when choosing the right program. The cheapest psych np programs provide budget-friendly options without compromising quality, making advanced nursing degrees more accessible to students passionate about immunology and patient care.

Best Scientists Citing Wolf-Henning Boehncke

Trending Scientists

Recently Published Articles